UT Southwestern Medical Center is widely recognized as one of the nation’s leading clinical and research centers for lipid metabolism and lipid disorders, which affect the way cholesterol is used by the body. Our program is dedicated to developing advanced diagnostic techniques and treatment approaches that prevent or minimize the risk of cardiovascular disease and strokes caused by abnormalities in lipid metabolism.

Patients with diabetes, hypertension, a poorly functioning thyroid and abdominal obesity benefit from UT Southwestern’s lipid assessments, drug therapies, nutritional advice and exercise recommendations. Our Lipid Metabolism Program offers expert consultation and advanced treatments that help patients attain healthy cholesterol and triglyceride levels.

Exemplifying our commitment to advancing the science of lipid metabolism, ongoing studies by researchers at UT Southwestern have helped uncover the basis of many factors contributing to metabolic syndrome. The condition, which affects more than 47 million Americans, is a constellation of disorders of the body’s metabolism – such as abdominal obesity, hypertension and insulin resistance – that increase a person’s risk of heart disease, dangerous plaque buildup in artery walls and non-insulin dependent diabetes. UT Southwestern’s research has helped reveal promising targets for new drug therapies.

The Lipid Metabolism Program at UT Southwestern is dedicated to providing the interventional therapies needed to slow or reverse the progression of illnesses associated with lipid metabolism. Our physicians continually strive to apply their combined expertise, experience and medical resources to deliver the best health care available for patients facing increased health risks related to cholesterol, triglycerides and other metabolic disorders.